Liang Yu Tang - Net Worth and Insider Trading
Liang Yu Tang Net Worth
The estimated net worth of Liang Yu Tang is at least $766,080 dollars as of 2025-07-23. Liang Yu Tang is the Director of Nanjing Pharmaceutical Co Ltd and owns about 144,000 shares of Nanjing Pharmaceutical Co Ltd (SHSE:600713) stock worth over $766,080. Details can be seen in Liang Yu Tang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Liang Yu Tang has not made any transactions after 2010-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Liang Yu Tang
Liang Yu Tang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Liang Yu Tang owns 1 companies in total, including Nanjing Pharmaceutical Co Ltd (SHSE:600713) .
Click here to see the complete history of Liang Yu Tang’s form 4 insider trades.
Insider Ownership Summary of Liang Yu Tang
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600713 | Nanjing Pharmaceutical Co Ltd | 2010-06-22 | Director |
Liang Yu Tang Latest Holdings Summary
Liang Yu Tang currently owns a total of 1 stock. Liang Yu Tang owns 144,000 shares of Nanjing Pharmaceutical Co Ltd (SHSE:600713) as of June 22, 2010, with a value of $766,080.
Latest Holdings of Liang Yu Tang
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600713 | Nanjing Pharmaceutical Co Ltd | 2010-06-22 | 144,000 | 5.32 | 766,080 |
Holding Weightings of Liang Yu Tang
Liang Yu Tang Form 4 Trading Tracker
According to the SEC Form 4 filings, Liang Yu Tang has made a total of 0 transactions in Nanjing Pharmaceutical Co Ltd (SHSE:600713) over the past 5 years. The most-recent trade in Nanjing Pharmaceutical Co Ltd is the acquisition of 48,000 shares on June 22, 2010, which cost Liang Yu Tang around $264,240.
Insider Trading History of Liang Yu Tang
- 1
Liang Yu Tang Trading Performance
GuruFocus tracks the stock performance after each of Liang Yu Tang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Liang Yu Tang is -10.26%. GuruFocus also compares Liang Yu Tang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Liang Yu Tang within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Liang Yu Tang's insider trading performs compared to the benchmark.
Performance of Liang Yu Tang
Liang Yu Tang Ownership Network
Ownership Network List of Liang Yu Tang
Ownership Network Relation of Liang Yu Tang

Liang Yu Tang Owned Company Details
What does Nanjing Pharmaceutical Co Ltd do?
Who are the key executives at Nanjing Pharmaceutical Co Ltd?
Liang Yu Tang is the Director of Nanjing Pharmaceutical Co Ltd. Other key executives at Nanjing Pharmaceutical Co Ltd include Directors & senior managers luo xun jie , senior management Zhou Jian Jun , and senior management li wen jun .
Nanjing Pharmaceutical Co Ltd (SHSE:600713) Insider Trades Summary
Over the past 18 months, Liang Yu Tang made no insider transaction in Nanjing Pharmaceutical Co Ltd (SHSE:600713). Other recent insider transactions involving Nanjing Pharmaceutical Co Ltd (SHSE:600713) include a net purchase of 7,100 shares made by xiao hong , a net sale of 0 shares made by feng chuang , and a net sale of 0 shares made by zhang jing .
In summary, during the past 3 months, insiders sold 0 shares of Nanjing Pharmaceutical Co Ltd (SHSE:600713) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nanjing Pharmaceutical Co Ltd (SHSE:600713) were sold and 7,100 shares were bought by its insiders, resulting in a net purchase of 7,100 shares.
Nanjing Pharmaceutical Co Ltd (SHSE:600713)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nanjing Pharmaceutical Co Ltd Insider Transactions
Liang Yu Tang Mailing Address
Above is the net worth, insider trading, and ownership report for Liang Yu Tang. Currently GuruFocus does not have mailing address information for Liang Yu Tang.